AbbVie (ABBV) free cash flow was $17.8B in FY2025 (-0% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2025
$17.8B
-0%
2024
$17.8B
-19%
2023
$22.1B
-9%
2022
$24.2B
+10%
2021
$22.0B
+31%
2020
$16.8B
+31%
2019
$12.8B
-0%
2018
$12.8B
+36%
2017
$9.4B
+44%
2016
$6.6B
-6%
2015
$7.0B
+138%
2014
$2.9B
-49%
2013
$5.8B
-4%
2012
$6.0B
+2%
2011
$5.9B
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q2 2026
$3.1B
Q1 2026
$3.6B
Q4 2025
$4.9B
Q3 2025
$6.6B
Q2 2025
$4.9B
Q1 2025
$1.4B
Q4 2024
$6.8B
Q3 2024
$5.2B
Q2 2024
$2.0B
Q1 2024
$3.8B
Q4 2023
$4.5B
Q3 2023
$7.4B
Source: ABBV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.